Less Chemo, Better Results for Kids With High-Risk Leukemia? What Families Should Know

A large new trial swapped two rounds of intense chemo for an immune drug called blinatumomab in 709 children with high-risk leukemia. Here are the results, the trade-offs, what it could mean, and three questions to bring to the care team.